临床内科杂志2024,Vol.41Issue(2) :96-99.DOI:10.3969/j.issn.1001-9057.2024.02.007

肺腺癌患者癌组织人内源性逆转录病毒-H长末端重复关联蛋白2、淋巴细胞活化基因3、整合连接激酶表达情况及与临床病理特点的关系

Expression of human endogenous retrovirus-H long terminal repeat associated protein 2,lymphocyte-activation gene 3 and integrin-linked kinase in cancer tissues and their relationship with clinic pathology characteristics in patients with lung adenocarcinom

董亮亮 童春堂 郑明旭 李书阅
临床内科杂志2024,Vol.41Issue(2) :96-99.DOI:10.3969/j.issn.1001-9057.2024.02.007

肺腺癌患者癌组织人内源性逆转录病毒-H长末端重复关联蛋白2、淋巴细胞活化基因3、整合连接激酶表达情况及与临床病理特点的关系

Expression of human endogenous retrovirus-H long terminal repeat associated protein 2,lymphocyte-activation gene 3 and integrin-linked kinase in cancer tissues and their relationship with clinic pathology characteristics in patients with lung adenocarcinom

董亮亮 1童春堂 1郑明旭 1李书阅1
扫码查看

作者信息

  • 1. 252600 山东省聊城市第二人民医院呼吸内科
  • 折叠

摘要

目的 探究肺腺癌(LUAD)患者癌组织人内源性逆转录病毒-H长末端重复关联蛋白2(HHLA2)、淋巴细胞活化基因3(LAG-3)、整合连接激酶(ILK)表达情况及与临床病理特点的关系.方法 检测106例LUAD患者癌组织及癌旁组织HHLA2、LAG-3、ILK表达情况,根据3项指标在癌组织中的表达情况将所有患者分别分为HHLA2高表达组(85例)和HHLA2低表达组(21例)、LAG-3高表达组(65例)和LAG-3低表达组(41例)、ILK高表达组(78例)和ILK低表达组(28例).收集所有患者一般资料、临床病理资料及3年生存率并进行组间比较.结果 LUAD患者癌组织中HHLA2、LAG-3、ILK高表达患者比例均高于同指标低表达患者比例,癌旁组织中上述3项指标低表达患者比例均高于同指标高表达患者比例.HHLA2高表达组年龄≥60岁、淋巴结转移患者比例均高于HHLA2低表达组;LAG-3高表达组TNMⅢ、Ⅳ期、淋巴结转移、远处转移患者比例均高于LAG-3低表达组;ILK高表达组组织低分化、TNM Ⅲ、Ⅳ期、淋巴结转移、远处转移患者比例均高于ILK低表达组(P<0.05).HHLA2低表达组、LAG-3低表达组及ILK低表达组3年生存率均高于同指标高表达组(P<0.05).结论 HHLA2、LAG-3、ILK在LUAD患者癌组织中大部分呈高表达,且与临床病理特点、预后存在一定关系.

Abstract

Objective To explore the expression of human endogenous retrovirus-H long terminal repeat associated protein 2(HHLA2),lymphocyte-activation gene 3(LAG-3)and integrin-linked kinase(ILK)in cancer tissues and their relationship with clinic pathology characteristics in patients with lung adenocarcinoma(LUAD).Methods The expressions of HHLA2,LAG-3 and ILK in cancer tissues and para-cancerous tissues of 106 LUAD patients were detected.According to the expressions of 3 indexes in cancer tissues,all patients were divided into high-expression HHLA2 group(85 cases)and low-expression HHLA2 group(21 cases),high-expression LAG-3 group(65 cases)and low-expression LAG-3 group(41 cases),high-expression ILK group(78 cases)and low-expression ILK group(28 cases).General data,clinic pathology data and 3-year survival rate were collected and compared between groups.Results The expression levels of HHLA2,LAG-3 and ILK were high in cancer tissues,while which were low in para-cancerous tissues(P<0.05).The proportions of age≥60 years and lymph node metastasis in HHLA2 high-expression group were higher than those in low-expression HHLA2 group;The proportions of TNM staging at stage Ⅲ and Ⅳ,lymph node metastasis and distant metastasis in high-expression LAG-3 group were higher than those in low-expression LAG-3 group;The proportions of low tissue differentiation,TNM staging at stage Ⅲ and Ⅳ,lymph node metastasis and distant metastasis in high-expression ILK group were higher than those in low-expression ILK group(P<0.05).3-year survival rates in low-expression HHLA2,LAG-3 and ILK groups were higher than those in corresponding high-expression groups(P<0.05).Conclusion The expressions of HHLA2,LAG-3 and ILK in cancer tissues are up-regulated in LUAD patients,which have certain relationship with clinic pathology characteristics and prognosis.

关键词

肺腺癌/人内源性逆转录病毒-H长末端重复关联蛋白2/淋巴细胞活化基因3/整合连接激酶/临床病理

Key words

Lung adenocarcinoma/Human endogenous retrovirus-H long terminal repeat associated protein 2/Lymphocyte-activation gene 3/Integrin-linked kinase/Clinic pathology

引用本文复制引用

出版年

2024
临床内科杂志
中华医学会湖北分会

临床内科杂志

CSTPCD
影响因子:0.922
ISSN:1001-9057
参考文献量17
段落导航相关论文